SCHEMBL21031210

SCHEMBL21031210

Cc1cc(-c2ccc(-c3ccccc3)cc2)nc(-c2cccc(-c3ccccc3)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
MEN1 O00255 9/20 0.50
KMT2A Q03164 9/20 0.50
MAPT P10636 5/20 0.50
HPGD P15428 5/20 0.50
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 3/20 0.50
NTSR1 P30989 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.46
GLA P06280 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18731969 0.98 LMNA (0.53) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL16922527 0.95 LMNA (0.53) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL16922596 0.93 LMNA (0.56) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL17779502 0.91 LMNA (0.58) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL25491455 0.91 LMNA (0.61) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL16922505 0.91 LMNA (0.61) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL16376450 0.91 LMNA (0.61) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL16373471 0.91 LMNA (0.61) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL19039847 0.88 MEN1 (0.50) LMNAMEN1KMT2AMAPTHPGD
SCHEMBL21636364 0.88 ABCG2 (0.55) LMNAMEN1KMT2AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 LMNA 2539/4885MEN1 3802/4885KMT2A 1221/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 LMNA 2539/4885MEN1 3802/4885KMT2A 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.